HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 123 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $585,000 | -29.8% | 65,904 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $833,000 | -35.9% | 65,904 | -1.1% | 0.00% | -33.3% |
Q1 2022 | $1,300,000 | -34.4% | 66,604 | +17.5% | 0.00% | -25.0% |
Q4 2021 | $1,982,000 | -5.0% | 56,704 | 0.0% | 0.00% | -20.0% |
Q3 2021 | $2,087,000 | +4.7% | 56,704 | +11.6% | 0.01% | 0.0% |
Q2 2021 | $1,994,000 | +29.3% | 50,804 | -7.3% | 0.01% | +25.0% |
Q1 2021 | $1,542,000 | +7.7% | 54,804 | +22.3% | 0.00% | +33.3% |
Q4 2020 | $1,432,000 | -2.8% | 44,804 | -1.8% | 0.00% | 0.0% |
Q3 2020 | $1,473,000 | +17.5% | 45,604 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $1,254,000 | +61.2% | 45,604 | +4.8% | 0.00% | +50.0% |
Q1 2020 | $778,000 | -30.0% | 43,504 | -2.7% | 0.00% | 0.0% |
Q4 2019 | $1,112,000 | +12.1% | 44,704 | -19.6% | 0.00% | 0.0% |
Q3 2019 | $992,000 | -18.9% | 55,604 | 0.0% | 0.00% | -33.3% |
Q2 2019 | $1,223,000 | +51.2% | 55,604 | +109.8% | 0.00% | +50.0% |
Q1 2019 | $809,000 | +42.2% | 26,504 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $569,000 | – | 26,504 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Zeal Asset Management Ltd | 2,684,118 | $84,523,000 | 16.48% |
Cederberg Capital Ltd | 3,400,000 | $108,868,000 | 2.00% |
Capital International Sarl | 570,500 | $18,267,000 | 1.91% |
AIA Group Ltd | 437,118 | $14,971,000 | 1.72% |
Capital International, Inc./CA/ | 4,711,405 | $150,859,000 | 1.40% |
M&G INVESTMENT MANAGEMENT LTD | 3,096,345 | $99,083,000 | 0.62% |
Bellevue Group AG | 947,674 | $30,345,000 | 0.35% |
Sands Capital Management | 7,051,916 | $225,802,000 | 0.22% |
E Fund Management (Hong Kong) Co., Ltd. | 18,836 | $603,000 | 0.21% |
Hudson Bay Capital Management LP | 1,031,212 | $33,020,000 | 0.18% |